Pizzie Nick Insider Trading Activity

Average Profitability
84.72%
Insider Buys Quantity
6
Insider Buys Sum
$447,323.91
Insider Sells Quantity
2
Insider Sells Sum
$1.95M

Insider Activity of Pizzie Nick

According to the SEC Form 4 filings, Pizzie Nick, being in a position of

  1. Chief Financial Officer at Axsome Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 45000 shares for $10.18M,
    over all time since 2018-06-19, has bought 78632 shares for $447,324, and sold 60000 shares for $12.13M.

Biography of Pizzie Nick

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $10,178,0102100

Comparison of Insiders on Amount of Buys and Sells

2026-06-09SaleAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
33,000
0.0655%
$240.09$7.92M-13.88%
2026-01-22SaleAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
12,000
0.0239%
$187.92$2.26M+6.44%
2025-02-14SaleAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
3,000
0.0062%
$131.07$393,210-8.25%
2025-02-13SaleAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
12,000
0.0244%
$129.86$1.56M-8.6%
2021-11-18PurchaseAxsome Therapeutics, Inc.
AXSM
CHIEF FINANCIAL OFFICER
955
0.0025%
$35.26$33,676+4.03%
2020-06-29PurchaseAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
777
0.0021%
$76.64$59,549-5.1%
2019-09-26PurchaseAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
2,180
0.0063%
$24.80$54,064+210.19%
2019-06-11PurchaseAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
1,920
0.0057%
$20.80$39,936+117.89%
2019-03-19PurchaseAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
10,800
0.0159%
$6.29$67,939+96.6%
2018-06-19PurchaseAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
62,000
0.2484%
$3.10$192,160+30.33%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.